Gene therapy for alzheimers disease

For the development of new medical drugs, it is necessary to gain a deeper understanding of the genetic factors of alzheimers disease, the roles of amyloid  and tau protein, and the mechanisms involved in neuronal degeneration. The current therapeutic mechanism of alzheimers is  to provide maximum support for the functions of the neurons remaining in the patient’s brain. The latest research direction dementia of the alzheimer type focuses on early diagnosis, given that the medication that is administered upon the initial manifestation of memory loss can help to maintain the quasi-normal state of cognitive functions longer.